Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

I ask because I'm in the process of weighing options because I've gotten different recommendations on when to start treatment. Thanks.

February 6
 · 
Be the first to react
IgG and IgA Antibodies in Myeloma: Which Is More Aggressive? Read Article...
A MyMyelomaTeam Member

Hi Joe, you will need a bone marrow biopsy and a full work up to confirm myeloma. They recommend we see a myeloma specialist from the start.

February 6 (edited)
MyMyelomaTeam

Does a high IgA level with low IgG and IgM indicate IgA myeloma and a more aggressive condition?

Your elevated IgA level combined with low IgG and IgM could suggest IgA myeloma, but your doctor will need additional tests to confirm this. The pattern you're describing—one antibody type being very high while others are Show Full Answer

Does a high IgA level with low IgG and IgM indicate IgA myeloma and a more aggressive condition?

Your elevated IgA level combined with low IgG and IgM could suggest IgA myeloma, but your doctor will need additional tests to confirm this. The pattern you're describing—one antibody type being very high while others are low—is common in myeloma.

IgA myeloma does tend to be more aggressive than other types. Here's what research shows:

- It grows faster and spreads more easily
- It has higher relapse rates after treatment
- It's more often linked to genetic changes that make cancer harder to treat
- It's more likely to form tumors outside the bone marrow (extramedullary plasmacytomas)
- It can be harder to track on standard blood tests

About 1 in 5 people with myeloma have the IgA type, making it the second most common form after IgG. Your doctor will likely use tests like immunofixation electrophoresis (IFE) to confirm your myeloma subtype and may track your M protein levels over time. Since IgA myeloma can be more aggressive, this information could influence when your oncology team recommends starting treatment.

Given that you're weighing different treatment timing recommendations, it's worth discussing with your doctors how your specific IgA level and any other test results (like genetic markers or staging information) factor into their recommendations. The aggressiveness of IgA myeloma is one consideration, but your complete clinical picture matters most.

February 6

Related Questions

View All